Frequently Asked Questions
The market is segmented based on Segmentation, By Ingredient (Vitamins, Botanicals, Minerals, Proteins and Amino Acids, Fibers and Specialty Carbohydrates, Omega Fatty Acids, and Others), Application (Energy and Weight Management, General Health, Bone and Joint Health, Gastrointestinal Health, Immunity, Cardiac Health, Diabetes, Anti-Cancer, and Others), End User (Adults, Geriatric, Pregnant Women, Children, and Infants), Distribution Channel (Store-Based and Non Store-Based) – Industry Trends and Forecast to 2031.
.
The Global Gummy Dietary Supplements Market size was valued at USD 8.00 USD Billion in 2023.
The Global Gummy Dietary Supplements Market is projected to grow at a CAGR of 8.9% during the forecast period of 2024 to 2031.
The major players operating in the market include Amway Corp. (U.S.), Abbott (U.S.), Arkopharma (France), Bayer AG (Germany), Glanbia plc (Ireland), Pfizer Inc. (U.S.), ADM (U.S.), Carlyle Nutritionals, LLC (U.S.), Nu Skin Enterprises Inc. (U.S.), Herbalife International of America, Inc. (U.S.), Nature's Sunshine Products, Inc. (U.S.), Bionova (Finland), Stepan Company (U.S.), Himalaya Wellness Company (India), and Otsuka Pharmaceutical Co. Ltd. (Japan).
The market report covers data from the U.S., Canada, Mexico in North America, Germany, Sweden, Poland, Denmark, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe in Europe, Japan, China, India, South Korea, New Zealand, Vietnam, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), Brazil, Argentina, Rest of South America as a part of South America, U.A.E, Saudi Arabia, Oman, Qatar, Kuwait, South Africa, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).
